Clinical Chemistry and Laboratory Medicine (CCLM)
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection | Nature Medicine
Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine
COVID-19 NAb Test Rapido Quantitativo per il dosaggio degli Anticorpi Neutralizzanti - Bioforniture
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS‐CoV‐2 infection or vaccination - Wilkins - 2022 - Clinical & Translational Immunology - Wiley Online Library
Comprehensive analysis of SARS-CoV-2 immune responses | Omnia Health Insights
COVID-19 NAb Test Rapido Quantitativo per il dosaggio degli Anticorpi Neutralizzanti - Bioforniture
COVID-19 NAb Test Rapido Quantitativo per il dosaggio degli Anticorpi Neutralizzanti - Bioforniture
Presentazione standard di PowerPoint
Frontiers | The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study | medRxiv
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection | Nature Medicine
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays | medRxiv
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article - ScienceDirect
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Frontiers | The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection - eBioMedicine
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays | medRxiv
Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection - eBioMedicine
Test sierologico ricerca anticorpi neutralizzanti IgM IgG, proteina spike
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays | medRxiv
